HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedEUCTR 2006-003659-19

A Double Blind, Placebo- and Active-Controlled, Randomized, Sequential Group, Multiple Dose Study to Examine the Effect of the CRF1-Receptor Antagonist R317573 on 7.5% CO2-Inhalation Induced Anxiet...

This historical record does not confirm current site availability.

Historical research recordUnited KingdomAnxiety
The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
United Kingdom
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study clarity

Study information

Study start dateNot clearly listed
Recruitment status
Completed
Enrollment listed in the registry
32
Sponsor
Janssen-Cilag International N.V.
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United Kingdom
Age range
Not clearly listed
Official registry ID
EUCTR 2006-003659-19
Official title
Show the full official title

A Double Blind, Placebo- and Active-Controlled, Randomized, Sequential Group, Multiple Dose Study to Examine the Effect of the CRF1-Receptor Antagonist R317573 on 7.5% CO2-Inhalation Induced Anxiet...

Looking for a study you can join?

Explore recruiting studies

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Completed

United Kingdom

Checked Official study record (opens in a new tab)
Registry details
Historical country statuses
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Janssen-Cilag International N.V.

Explore other studies

Want to find a study that may fit you better?

Explore HopeStage studies by mental health topic and refine the results to suit your situation.

Find a study that may fit me